Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Associations Between Gene Variants of Lipid-Lowering Drug Targets and Adverse Outcomes After Ischemic Stroke.

Journal of the American Heart Association - 19 Nov 2024

Sun Lulu, Zhang Qilu, Shi Mengyao, Liu Yang, Zhu Zhengbao, Zhang Jing, Peng Hao, Wang Aili, Chen Jing, Xu Tan, Zhang Yonghong, He Jiang

Abstract excerpt

BACKGROUND: The association of lipid-lowering drug targets and their gene variants with cardiovascular diseases has been previously clarified. However, the relationship between gene variants of lipid-lowering drug targets and the adverse prognosis of ischemic stroke patients remains unclear. METHODS AND RESULTS: Multiple single-nucleotide polymorphisms associated with 6 lipid-lowering drug targets were genotyped...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol Ester Transfer Proteins
Share to Hydroxymethylglutaryl CoA Reductases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypolipidemic Agents

Share to Ischemic Stroke

Share to Pharmacogenomic Variants

Share to Proprotein Convertase 9

Share to Risk Assessment

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 39547981
DOI: 10.1161/JAHA.124.036544
PMCID: PMC11681404

Genes

CETP
HMGCR
PCSK9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Associations Between Gene Variants of Lipid-Lowering Drug Targets and Adverse Outcomes After Ischemic Stroke.PMID 39547981Read ↗

Common genetic variation in six lipid-related and statin-related genes, statin use and risk of incident nonfatal myocardial infarction and stroke.Semantic proximity Read ↗

Single Nucleotide Polymorphisms in Stroke: Evidence Across Susceptibility, Prognosis, and Recurrence; A Systematic Review.Semantic proximity Read ↗

Genetic risk impacts stroke mortality and pathogenesis in patients with ischemic stroke: cohort study of BioBank JapanSemantic proximity Read ↗

Gene variants associated with ischemic stroke: the cardiovascular health study.Semantic proximity Read ↗

Lipid Metabolism Genes in Stroke Pathogenesis: The AtherosclerosisSemantic proximity Read ↗

Association between high-density lipoprotein and functional outcome of ischemic stroke patients in a Taiwanese population.Semantic proximity Read ↗

The Role of Genetics in Stroke Risk and Outcome: A Review of Current Evidence.Semantic proximity Read ↗

Individual and summed effects of high-risk genetic polymorphisms on recurrent cardiovascular events following ischemic heart disease.Semantic proximity Read ↗

Stroke Risk Factors, Genetics, and Prevention.Semantic proximity Read ↗

Systematic Druggable Genome-Wide Mendelian Randomization Identifies Therapeutic Targets for Functional Outcome After Ischemic Stroke.Semantic proximity Read ↗

Gene Polymorphisms Affect the Effectiveness of Atorvastatin in Treating Ischemic Stroke Patients.Semantic proximity Read ↗

Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood ProteomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.